eXoZymes Inc.

Animal Exploitation (Testing): Yes Link: https://markets.financialcontent.com/wral/article/accwirecq-2025-7-29-exozymes-details-biomanufacturing-breakthrough-4-grams-of-nct-with-over-99-purity Short Description: The company, through its spin-out NCTx, is developing compounds with pharmaceutical and nutraceutical potential, and the preclinical safety and efficacy studies for these compounds have been conducted using animal models (Tangential/Animal Testing).